EPT - Consolidated Statements of Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common stock	Additional paid-in capital	Distributions in excess of accumulated earnings	Accumulated other comprehensive income (loss), net	Noncontrolling interest
Beginning balance (in shares) at Dec. 31, 2022		64,605
Beginning balance at Dec. 31, 2022	$ 5,895,116	$ 6	$ 6,750,076	$ (1,080,176)	$ 46,466	$ 178,744
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	430,708			405,825		24,883
Reversal of unrealized gains upon the sale of marketable debt securities	0
Change in fair value of derivatives and amortization of swap settlements	(13,364)				(12,910)	(454)
Change in fair value of marketable debt securities, net	0
Issuance of common stock under:
Stock option and restricted stock plans, net (in shares)		21
Stock option and restricted stock plans, net	(3,825)		(3,825)
Sale of common stock, net	(347)		(347)
Equity based compensation costs	12,135		11,723			412
Retirement of common stock, net (in shares)		(437)
Retirement of common stock, net	(95,657)		(95,657)
Changes in the redemption value of redeemable noncontrolling interest	(5,055)		(5,150)			95
Distributions to noncontrolling interest	(31,939)					(31,939)
Redemptions of noncontrolling interest (in shares)		14
Redemptions of noncontrolling interest	(609)		(100)			(509)
Common stock dividends	(593,185)			(593,185)
Ending balance (in shares) at Dec. 31, 2023		64,203
Ending balance at Dec. 31, 2023	5,593,978	$ 6	6,656,720	(1,267,536)	33,556	171,232
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	811,306			741,522		69,784
Reversal of unrealized gains upon the sale of marketable debt securities	0
Change in fair value of derivatives and amortization of swap settlements	(9,217)				(8,901)	(316)
Change in fair value of marketable debt securities, net	0
Issuance of common stock under:
Stock option and restricted stock plans, net (in shares)		70
Stock option and restricted stock plans, net	9,096		9,096
Sale of common stock, net	(296)		(296)
Equity based compensation costs	7,671		7,408			263
Changes in the redemption value of redeemable noncontrolling interest	835		373			462
Issuance of OP units to noncontrolling interest	24,930					24,930
Distributions to noncontrolling interest	(81,812)					(81,812)
Redemptions of noncontrolling interest (in shares)		7
Redemptions of noncontrolling interest	(6,453)		(5,254)			(1,199)
Common stock dividends	(629,648)			(629,648)
Ending balance (in shares) at Dec. 31, 2024		64,280
Ending balance at Dec. 31, 2024	5,720,390	$ 6	6,668,047	(1,155,662)	24,655	183,344
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	702,773			669,666		33,107
Reversal of unrealized gains upon the sale of marketable debt securities	(27)				(26)	(1)
Change in fair value of derivatives and amortization of swap settlements	(19,508)				(18,818)	(690)
Change in fair value of marketable debt securities, net	244				236	8
Issuance of common stock under:
Stock option and restricted stock plans, net (in shares)		81
Stock option and restricted stock plans, net	816		816
Sale of common stock, net	(391)		(391)
Equity based compensation costs	10,224		9,879			345
Changes in the redemption value and redemptions of redeemable noncontrolling interest (in shares)		6
Changes in the redemption value of redeemable noncontrolling interest	2,586		2,805			(219)
Distributions to noncontrolling interest	(32,801)					(32,801)
Redemptions of noncontrolling interest (in shares)		75
Redemptions of noncontrolling interest	(13,475)		2,358			(15,833)
Common stock dividends	(662,199)			(662,199)
Ending balance (in shares) at Dec. 31, 2025		64,442
Ending balance at Dec. 31, 2025	$ 5,708,632	$ 6	$ 6,683,514	$ (1,148,195)	$ 6,047	$ 167,260